No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Patent Ductus Arteriosus Drug market is a subset of the Cardiovascular Drugs market. It is composed of drugs used to treat Patent Ductus Arteriosus (PDA), a congenital heart defect in which the ductus arteriosus fails to close after birth. These drugs are used to reduce the size of the PDA and improve blood flow to the lungs. Commonly used drugs include indomethacin, ibuprofen, and prostaglandin E1. These drugs are administered orally, intravenously, or through inhalation.
The Patent Ductus Arteriosus Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies include AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more
